Ethics

HHS should look into Azar’s close ties to the drug industry

"Given the significance of this issue, it is critical that the American people have confidence that the proposed changes are based on sound policy. This is why my organization, Campaign for Accountability a nonprofit, nonpartisan watchdog group focused on public accountability, called on ethics officials at HHS to open an investigation into HHS Secretary Alex Azar and his relationship with his former employer, the pharmaceutical manufacturing giant Eli Lilly."

Watchdog Calls on HHS to Release Sec. Azar’s Communications with Former Employer Eli Lilly

On August 30, 2018, CfA filed a Freedom of Information Act (FOIA) request with the Department of Health and Human Services (HHS) seeking communications between Sec. Alex Azar, and any representative or lobbyist for Eli Lilly and Company. Sec. Azar worked at Eli Lilly for a decade, and he has supported a proposed rule change at HHS that would greatly benefit the pharmaceutical manufacturer.

Watchdog Calls for Investigation into HHS Secretary Azar’s Relationship with Former Employer Eli Lilly Following Proposed Rule Change

On August 28, 2018, CfA called on ethics officials at the Department of Health and Human Services (HHS) to open an investigation into HHS Secretary Alex Azar and his relationship with his former employer, the pharmaceutical manufacturer Eli Lilly and Company. HHS recently proposed a new rule that would greatly benefit Eli Lilly, and Sec. Azar has championed the issue while at the helm of HHS.

Government Watchdog Files Ethics Complaint Against Rep. Devin Nunes for Lying About His Investments in Several California Companies

On July 11, 2018, CfA called on the Office of Congressional Ethics to investigate whether Rep. Devin Nunes (R-CA) violated federal law and House rules by failing to accurately disclose his investments in three California companies on his personal financial disclosures.

Get the latest news and actions

Sign up for updates